Skip to content
★ Sign in to follow
CT

Curtis T. Keith

EPIRUS Biopharmaceuticals, Inc.
Total declarations
28
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (21 ops.)
€140k

Latest filing published 29 Jan 2008 for EPIRUS Biopharmaceuticals, Inc., €8,324.

Insider track record

Disclosed buys
0
Disclosed sells
21
Signal history

No signal scores available.

Curtis T. Keith: trading record in brief

This profile gathers the share dealings of Curtis T. Keith in EPIRUS Biopharmaceuticals, Inc. The record holds 28 filings, for trades running from 26 January 2006 to 26 January 2008.

No open-market purchase appears, only 21 sales worth €140k. Outside the open market, there are 2 share grants and 5 option exercises.

The newest entry dates from 29 January 2008: a share grant of €8,324, in EPIRUS Biopharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Curtis T. Keith

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations27 total

25 of 27 declarations